Difference between revisions of "CD16-30"
From Opengenome.net
(2 intermediate revisions by the same user not shown) | |||
Line 23: | Line 23: | ||
<td> FCγRⅢA</td> | <td> FCγRⅢA</td> | ||
<td> Macrophage, NK cells, neutrophils</td> | <td> Macrophage, NK cells, neutrophils</td> | ||
− | <td> | + | <td> Subunit of low-affinity Fc receptor, involved in phagocytosis of antibody-complexed antien and in antibody-dependent cell-mediated cytotosicity (ADCC)</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 34: | Line 34: | ||
<tr> | <tr> | ||
<td><strong> CD18</strong></td> | <td><strong> CD18</strong></td> | ||
− | <td> </td> | + | <td> 95</td> |
− | <td> | + | <td> β2 integrin chain; β subunit that combines with CD11a, CD11b, or CD11c subunit to form integrins</td> |
− | <td> | + | <td> All leukocytes </td> |
− | <td> | + | <td> Adhesion and signaling in the hematopoietic system (see entries for CD11a, CD11b, and CD11c) </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD19</strong></td> | <td bgcolor="#cccccc"><strong> CD19</strong></td> | ||
− | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> >120</td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> B4 </td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> Follicular dendritic cells, B cells from earliest recognizable B-lineage cells during development to B-cell blasts but lost on maturation to plasma cells </td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> Part of B-cell coreceptor with CD21 and CD81; a critical signal transduction molecule that regulates B-cell development, activation, and differentiation</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD20</strong></td> | <td><strong> CD20</strong></td> | ||
− | <td> </td> | + | <td> 33</td> |
− | <td> | + | <td> B1, Bp35 </td> |
− | <td> | + | <td> B cells </td> |
− | <td> | + | <td> Not known </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD21</strong></td> | <td bgcolor="#cccccc"><strong> CD21</strong></td> | ||
− | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 145 (membrane form)<br /> |
− | <td bgcolor="#cccccc"> | + | 130 (soluble form)</td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> C3d receptor, CR2, Epstein Barr virus receptor (EBV-R) </td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> B cells, follicular dendritic cells, subset of immature thymocytes </td> |
+ | <td bgcolor="#cccccc"> Receptor for EBV, C3d, C3dg, and iC3b; with CD19 and CD81, part of the B-cell coreceptor, a large signal-transduction complex </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD22</strong></td> | <td><strong> CD22</strong></td> | ||
− | <td> </td> | + | <td> 140</td> |
− | <td> | + | <td> BL-CAM, Lyb8 in mouse</td> |
− | <td> | + | <td> Surface of mature B cells, cytoplasm of late pro-and early pre-B cells </td> |
− | <td> | + | <td> Adhesion molecule; signaling molecule </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD23</strong></td> | <td bgcolor="#cccccc"><strong> CD23</strong></td> | ||
− | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 45</td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> B6, BLAST-2, FcεRⅡ, Leu-20 ; low-affinity IgE receptor </td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> Human B cells, monocytes follicular dendritic cells </td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> Regulation of IgE synthesis; trigger to release TNF, IL-1, IL-6, and GM-CSF from human monocytes </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD24</strong></td> | <td><strong> CD24</strong></td> | ||
− | <td> </td> | + | <td> 35-45</td> |
− | <td> | + | <td> BA-1, heat-stable antigen (HSA) in mouse </td> |
− | <td> | + | <td> B-cell lineage but lost at plasma-cell stage, mature granulocytes </td> |
− | <td> | + | <td> Not known </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD25</strong></td> | <td bgcolor="#cccccc"><strong> CD25</strong></td> | ||
− | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 55</td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> IL-2 receptor α chain, IL-2R, Tac antogen </td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> PHA-stimulated T cells; anti-IGM-stimulated B cells, LPS-stimulated monocytes/macrophages </td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> α subunit of receptor for cytokine IL-2 </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD26</strong></td> | <td><strong> CD26</strong></td> | ||
− | <td> </td> | + | <td> 110, 120</td> |
− | <td> | + | <td> EC 3.4.14.5, adenosine deaminase-binding protein (ADA-binding protein), dipeptidylpeptidase Ⅳ (DPV Ⅳ ectoenzyme) </td> |
− | <td> | + | <td> Mature of activated T cells, B cells, NK cells, macrophages</td> |
− | <td> | + | <td> Co-stimulatory molecule in T-cell activation </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td bgcolor="#cccccc"><strong> | + | <td bgcolor="#cccccc"><strong> CD27</strong></td> |
− | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 55</td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> SI52, T14 </td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> Mature thymocytes, activated T cells and B cells, NK cells, macrophages, most peropheral T cells, memory-type B cells </td> |
− | <td bgcolor="#cccccc"> | + | <td bgcolor="#cccccc"> Mediation of a co-stimulatory signal for T- and B-cell activation; role in murine T-cell development </td> |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td | + | <td><strong> CD28</strong></td> |
− | <td | + | <td> 90 (homodimeric form)</td> |
− | <td | + | <td> T44, Tp44 </td> |
− | <td | + | <td> Matur CD3+ thymocytes, most peripheral T cells, plasma cells </td> |
− | <td | + | <td> Co-stimulation of T-cell proliferation and cytokine production upon binding CD80 or CD86 </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td><strong> CD29</strong></td> | + | <td bgcolor="#cccccc"><strong> CD29</strong></td> |
− | <td> </td> | + | <td bgcolor="#cccccc"> 130</td> |
− | <td> | + | <td bgcolor="#cccccc"> β1 integrin chain, GP, platelet GPⅡa, VLA-β chain </td> |
− | <td> | + | <td bgcolor="#cccccc"> Leukocytes </td> |
− | <td> | + | <td bgcolor="#cccccc"> β subunit of VLA-1 integrin </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td | + | <td><strong> CD30</strong></td> |
− | <td | + | <td> 120</td> |
− | <td | + | <td> Ber-H2 antigen, Ki-1 antigen </td> |
− | <td | + | <td> Activated T cells, activated B cells, activated NK cells, monocytes </td> |
− | <td | + | <td> Stimulation of proliferation or induction of cell death, depending upon conditions and cell type expressing it </td> |
</tr> | </tr> | ||
</tbody> | </tbody> | ||
</table> | </table> |
Latest revision as of 14:35, 5 September 2006
CD antigen |
MW.(kDa) |
Synonyms & Properties |
Leukocyte expression |
Function |
CD16 | 50-80 | FCγRⅢA | Macrophage, NK cells, neutrophils | Subunit of low-affinity Fc receptor, involved in phagocytosis of antibody-complexed antien and in antibody-dependent cell-mediated cytotosicity (ADCC) |
CDw17 | Lactosylceramide (LacCer); carbohydrate antigen | Monocytes, granulocytes, basophils, platelets, subset of peripheral B cells (CD19+), tonsillar dendritic cells | Not known; ability to bind bacteria for possible role in phagocytosis | |
CD18 | 95 | β2 integrin chain; β subunit that combines with CD11a, CD11b, or CD11c subunit to form integrins | All leukocytes | Adhesion and signaling in the hematopoietic system (see entries for CD11a, CD11b, and CD11c) |
CD19 | >120 | B4 | Follicular dendritic cells, B cells from earliest recognizable B-lineage cells during development to B-cell blasts but lost on maturation to plasma cells | Part of B-cell coreceptor with CD21 and CD81; a critical signal transduction molecule that regulates B-cell development, activation, and differentiation |
CD20 | 33 | B1, Bp35 | B cells | Not known |
CD21 | 145 (membrane form) 130 (soluble form) |
C3d receptor, CR2, Epstein Barr virus receptor (EBV-R) | B cells, follicular dendritic cells, subset of immature thymocytes | Receptor for EBV, C3d, C3dg, and iC3b; with CD19 and CD81, part of the B-cell coreceptor, a large signal-transduction complex |
CD22 | 140 | BL-CAM, Lyb8 in mouse | Surface of mature B cells, cytoplasm of late pro-and early pre-B cells | Adhesion molecule; signaling molecule |
CD23 | 45 | B6, BLAST-2, FcεRⅡ, Leu-20 ; low-affinity IgE receptor | Human B cells, monocytes follicular dendritic cells | Regulation of IgE synthesis; trigger to release TNF, IL-1, IL-6, and GM-CSF from human monocytes |
CD24 | 35-45 | BA-1, heat-stable antigen (HSA) in mouse | B-cell lineage but lost at plasma-cell stage, mature granulocytes | Not known |
CD25 | 55 | IL-2 receptor α chain, IL-2R, Tac antogen | PHA-stimulated T cells; anti-IGM-stimulated B cells, LPS-stimulated monocytes/macrophages | α subunit of receptor for cytokine IL-2 |
CD26 | 110, 120 | EC 3.4.14.5, adenosine deaminase-binding protein (ADA-binding protein), dipeptidylpeptidase Ⅳ (DPV Ⅳ ectoenzyme) | Mature of activated T cells, B cells, NK cells, macrophages | Co-stimulatory molecule in T-cell activation |
CD27 | 55 | SI52, T14 | Mature thymocytes, activated T cells and B cells, NK cells, macrophages, most peropheral T cells, memory-type B cells | Mediation of a co-stimulatory signal for T- and B-cell activation; role in murine T-cell development |
CD28 | 90 (homodimeric form) | T44, Tp44 | Matur CD3+ thymocytes, most peripheral T cells, plasma cells | Co-stimulation of T-cell proliferation and cytokine production upon binding CD80 or CD86 |
CD29 | 130 | β1 integrin chain, GP, platelet GPⅡa, VLA-β chain | Leukocytes | β subunit of VLA-1 integrin |
CD30 | 120 | Ber-H2 antigen, Ki-1 antigen | Activated T cells, activated B cells, activated NK cells, monocytes | Stimulation of proliferation or induction of cell death, depending upon conditions and cell type expressing it |